United States of America (USA) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Summary
Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The US pharmaceuticals market had total revenues of $397.0 billion in 2021, representing a compound annual growth rate (CAGR) of 4.3% between 2016 and 2021.
- The US government continued to invest heavily in pharmaceutical companies in 2021 to accelerate the development, manufacture, and procurement of COVID-19 vaccines and therapeutics. This has resulted in stable growth of the pharmaceuticals market.
- New policies by the US government to reduce the pricing of medications and build an affordable healthcare system could contribute to a slowdown in market growth. As healthcare becomes more affordable and accessible, the ability of pharmaceutical companies to freely set prices will become limited.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts
- What was the size of the United States pharmaceuticals market by value in 2021?
- What will be the size of the United States pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the United States pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the United State's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market share
- 1.5. Market rivalry
- 1.6. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Market share
- 7.2. Who are the leading players?
- 7.3. What strategies do leading players follow?
- 7.4. What is the rationale behind recent M&A activity
- 7.5. How does government regulation impact leading players?
- 7.6. What impact is the COVID-19 pandemic having on the market?
- 8 Company Profiles
- 8.1. Johnson & Johnson
- 8.2. Pfizer Inc.
- 8.3. AstraZeneca PLC
- 8.4. Merck & Co., Inc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: United States pharmaceuticals market value: $ billion, 2016–21
- Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2021
- Table 3: United States pharmaceuticals market value forecast: $ billion, 2021–26
- Table 4: United States pharmaceuticals market share: % share, by value, 2021
- Table 5: Johnson & Johnson: key facts
- Table 6: Johnson & Johnson: Annual Financial Ratios
- Table 7: Johnson & Johnson: Key Employees
- Table 8: Johnson & Johnson: Key Employees Continued
- Table 9: Pfizer Inc.: key facts
- Table 10: Pfizer Inc.: Annual Financial Ratios
- Table 11: Pfizer Inc.: Key Employees
- Table 12: Pfizer Inc.: Key Employees Continued
- Table 13: AstraZeneca PLC: key facts
- Table 14: AstraZeneca PLC: Annual Financial Ratios
- Table 15: AstraZeneca PLC: Key Employees
- Table 16: AstraZeneca PLC: Key Employees Continued
- Table 17: Merck & Co., Inc.: key facts
- Table 18: Merck & Co., Inc.: Annual Financial Ratios
- Table 19: Merck & Co., Inc.: Key Employees
- Table 20: Merck & Co., Inc.: Key Employees Continued
- Table 21: United States size of population (million), 2017–21
- Table 22: United States gdp (constant 2005 prices, $ billion), 2017–21
- Table 23: United States gdp (current prices, $ billion), 2017–21
- Table 24: United States inflation, 2017–21
- Table 25: United States consumer price index (absolute), 2017–21
- Table 26: United States exchange rate, 2017–21
- List of Figures
- Figure 1: United States pharmaceuticals market value: $ billion, 2016–21
- Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2021
- Figure 3: United States pharmaceuticals market value forecast: $ billion, 2021–26
- Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2021
- Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2021
- Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2021
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2021
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2021
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2021
- Figure 10: United States pharmaceuticals market share: % share, by value, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook